Ganoderol B: A potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum

Sri Fatmawati, Kuniyoshi Shimizu, Ryuichiro Kondo

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

α-Glucosidase inhibitor has considerable potential as a diabetes mellitus type 2 drug because it prevents the digestion of carbohydrates. The search for the constituents reducing α-glucosidase activity led to the finding of active compounds in the fruiting body of Ganoderma lucidum. The CHCl 3 extract of the fruiting body of G. lucidum was found to show inhibitory activity on α-glucosidase in vitro. The neutral fraction, with an IC 50 of 88.7 μg/ml, had stronger inhibition than a positive control, acarbose, with an IC 50 of 336.7 μg/ml (521.5 μM). The neutral fraction was subjected to silica gel column chromatography and repeated p-HPLC to provide an active compound, (3β,24E)-lanosta-7,9(11),24-trien-3, 26-diol (ganoderol B). It was found to have high α-glucosidase inhibition, with an IC 50 of 48.5 μg/ml (119.8 μM).

Original languageEnglish
Pages (from-to)1053-1055
Number of pages3
JournalPhytomedicine
Volume18
Issue number12
DOIs
Publication statusPublished - Sep 15 2011

Fingerprint

Reishi
Glucosidases
Trientine
Acarbose
Silica Gel
Type 2 Diabetes Mellitus
Gel Chromatography
Digestion
High Pressure Liquid Chromatography
Carbohydrates
ganoderol B
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine

Cite this

Ganoderol B : A potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. / Fatmawati, Sri; Shimizu, Kuniyoshi; Kondo, Ryuichiro.

In: Phytomedicine, Vol. 18, No. 12, 15.09.2011, p. 1053-1055.

Research output: Contribution to journalArticle

@article{0b50c6d15b75448d985fc863356a9650,
title = "Ganoderol B: A potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum",
abstract = "α-Glucosidase inhibitor has considerable potential as a diabetes mellitus type 2 drug because it prevents the digestion of carbohydrates. The search for the constituents reducing α-glucosidase activity led to the finding of active compounds in the fruiting body of Ganoderma lucidum. The CHCl 3 extract of the fruiting body of G. lucidum was found to show inhibitory activity on α-glucosidase in vitro. The neutral fraction, with an IC 50 of 88.7 μg/ml, had stronger inhibition than a positive control, acarbose, with an IC 50 of 336.7 μg/ml (521.5 μM). The neutral fraction was subjected to silica gel column chromatography and repeated p-HPLC to provide an active compound, (3β,24E)-lanosta-7,9(11),24-trien-3, 26-diol (ganoderol B). It was found to have high α-glucosidase inhibition, with an IC 50 of 48.5 μg/ml (119.8 μM).",
author = "Sri Fatmawati and Kuniyoshi Shimizu and Ryuichiro Kondo",
year = "2011",
month = "9",
day = "15",
doi = "10.1016/j.phymed.2011.03.011",
language = "English",
volume = "18",
pages = "1053--1055",
journal = "Phytomedicine",
issn = "0944-7113",
publisher = "Urban und Fischer Verlag Jena",
number = "12",

}

TY - JOUR

T1 - Ganoderol B

T2 - A potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum

AU - Fatmawati, Sri

AU - Shimizu, Kuniyoshi

AU - Kondo, Ryuichiro

PY - 2011/9/15

Y1 - 2011/9/15

N2 - α-Glucosidase inhibitor has considerable potential as a diabetes mellitus type 2 drug because it prevents the digestion of carbohydrates. The search for the constituents reducing α-glucosidase activity led to the finding of active compounds in the fruiting body of Ganoderma lucidum. The CHCl 3 extract of the fruiting body of G. lucidum was found to show inhibitory activity on α-glucosidase in vitro. The neutral fraction, with an IC 50 of 88.7 μg/ml, had stronger inhibition than a positive control, acarbose, with an IC 50 of 336.7 μg/ml (521.5 μM). The neutral fraction was subjected to silica gel column chromatography and repeated p-HPLC to provide an active compound, (3β,24E)-lanosta-7,9(11),24-trien-3, 26-diol (ganoderol B). It was found to have high α-glucosidase inhibition, with an IC 50 of 48.5 μg/ml (119.8 μM).

AB - α-Glucosidase inhibitor has considerable potential as a diabetes mellitus type 2 drug because it prevents the digestion of carbohydrates. The search for the constituents reducing α-glucosidase activity led to the finding of active compounds in the fruiting body of Ganoderma lucidum. The CHCl 3 extract of the fruiting body of G. lucidum was found to show inhibitory activity on α-glucosidase in vitro. The neutral fraction, with an IC 50 of 88.7 μg/ml, had stronger inhibition than a positive control, acarbose, with an IC 50 of 336.7 μg/ml (521.5 μM). The neutral fraction was subjected to silica gel column chromatography and repeated p-HPLC to provide an active compound, (3β,24E)-lanosta-7,9(11),24-trien-3, 26-diol (ganoderol B). It was found to have high α-glucosidase inhibition, with an IC 50 of 48.5 μg/ml (119.8 μM).

UR - http://www.scopus.com/inward/record.url?scp=80052462119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052462119&partnerID=8YFLogxK

U2 - 10.1016/j.phymed.2011.03.011

DO - 10.1016/j.phymed.2011.03.011

M3 - Article

C2 - 21596546

AN - SCOPUS:80052462119

VL - 18

SP - 1053

EP - 1055

JO - Phytomedicine

JF - Phytomedicine

SN - 0944-7113

IS - 12

ER -